Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Haynes

Showing results (151-160 of 217) with videos related to

Pageof 22
Sort By:
Bone Marrow Transplantation|October 3, 1998
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxisJ L Byrne, C Stainer, H Hyde, et al.
Bone Marrow Transplantation|June 28, 2005
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantationN H Russell, J L Byrne, R D Faulkner, et al.
British Journal of Haematology|December 19, 1998
A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical courseJ L Byrne, G I Carter, J M Davies, et al.
Blood|April 1, 1997
Allogeneic bone marrow transplant for multiple myelomaN H Russell, G Miflin, C Stainer, et al.
Breast Cancer Research and Treatment|February 5, 2013
Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancerBen P Haynes, Giuseppe Viale, Viviana Galimberti, et al.
Bone Marrow Transplantation|May 7, 1999
Low incidence of human herpesvirus 8 in stem cell collections from myeloma patientsG M Cull, G I Carter, J M Timms, et al.
Journal of Medicinal Chemistry|August 16, 1996
3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancerF C Chan, G A Potter, S E Barrie, et al.
British Journal of Cancer|June 21, 2012
Long-term survival after treatment for Hodgkin's disease (1973-2002): improved survival with successive 10-year cohortsE M Bessell, G Bouliotis, S Armstrong, et al.
Lancet (London, England)|December 18, 1993
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentrationS R Johnston, B P Haynes, I E Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2011
Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancerH Anderson, M Hills, L Zabaglo, et al.
Pageof 22

Showing results (151-160 of 217) with videos related to

Sort By:
Pageof 22
Bone Marrow Transplantation|October 3, 1998
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxisJ L Byrne, C Stainer, H Hyde, et al.
Bone Marrow Transplantation|June 28, 2005
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantationN H Russell, J L Byrne, R D Faulkner, et al.
British Journal of Haematology|December 19, 1998
A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical courseJ L Byrne, G I Carter, J M Davies, et al.
Blood|April 1, 1997
Allogeneic bone marrow transplant for multiple myelomaN H Russell, G Miflin, C Stainer, et al.
Breast Cancer Research and Treatment|February 5, 2013
Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancerBen P Haynes, Giuseppe Viale, Viviana Galimberti, et al.
Bone Marrow Transplantation|May 7, 1999
Low incidence of human herpesvirus 8 in stem cell collections from myeloma patientsG M Cull, G I Carter, J M Timms, et al.
Journal of Medicinal Chemistry|August 16, 1996
3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancerF C Chan, G A Potter, S E Barrie, et al.
British Journal of Cancer|June 21, 2012
Long-term survival after treatment for Hodgkin's disease (1973-2002): improved survival with successive 10-year cohortsE M Bessell, G Bouliotis, S Armstrong, et al.
Lancet (London, England)|December 18, 1993
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentrationS R Johnston, B P Haynes, I E Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2011
Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancerH Anderson, M Hills, L Zabaglo, et al.
Pageof 22